| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | REYNOLDS AMERICAN INC | 16,407,290 | 726,351,000 | 41.94% | ||
| 2 | ALKERMES PLC SHS | 5,206,633 | 305,473,000 | 17.64% | ||
| 3 | ABBVIE INC | 5,277,800 | 287,165,000 | 16.58% | ||
| 4 | PROTHENA CORP PLC | 6,202,525 | 281,222,000 | 16.24% | ||
| 5 | NORTHWEST BIOTHERAPEUTICS INC | 20,461,392 | 127,884,000 | 7.38% | ||
| 6 | Theravance Biopharma Inc | 360,685 | 3,964,000 | 0.23% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001213900-17-005675, filed 2017.05.22).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
